Skip to main content

Mutations in ribonuclease L gene do not occur at a greater frequency in patients with familial prostate cancer compared with patients with sporadic prostate cancer.

Publication ,  Journal Article
Downing, SR; Hennessy, KT; Abe, M; Manola, J; George, DJ; Kantoff, PW
Published in: Clin Prostate Cancer
December 2003

Several genetic loci are suspected to be involved in hereditary prostate cancer, including the hereditary prostate cancer 1 (HPC1) locus at chromosome 1q24-25. The ribonuclease L (RNase L) gene has been reported as the putative hereditary prostate cancer gene located at HPC1. If this is the case, mutations of RNase L should be found at a greater frequency in familial cancers than in sporadic prostate cancers. Examination of familial and sporadic cases of prostate cancer by polymerase chain reaction and DNA sequencing resulted in a mutational frequency rate that was not statistically different between the 2 forms of the disease. These results suggest that the mutations examined within this study are rare and may contribute to very few familial prostate cancers.

Duke Scholars

Published In

Clin Prostate Cancer

DOI

ISSN

1540-0352

Publication Date

December 2003

Volume

2

Issue

3

Start / End Page

177 / 180

Location

United States

Related Subject Headings

  • Ribonucleases
  • Prostatic Neoplasms
  • Polymerase Chain Reaction
  • Oncology & Carcinogenesis
  • Mutation
  • Middle Aged
  • Male
  • Humans
  • Gene Frequency
  • DNA Mutational Analysis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Downing, S. R., Hennessy, K. T., Abe, M., Manola, J., George, D. J., & Kantoff, P. W. (2003). Mutations in ribonuclease L gene do not occur at a greater frequency in patients with familial prostate cancer compared with patients with sporadic prostate cancer. Clin Prostate Cancer, 2(3), 177–180. https://doi.org/10.3816/cgc.2003.n.027
Downing, Sean R., Kristen T. Hennessy, Miyako Abe, Judith Manola, Daniel J. George, and Philip W. Kantoff. “Mutations in ribonuclease L gene do not occur at a greater frequency in patients with familial prostate cancer compared with patients with sporadic prostate cancer.Clin Prostate Cancer 2, no. 3 (December 2003): 177–80. https://doi.org/10.3816/cgc.2003.n.027.
Downing SR, Hennessy KT, Abe M, Manola J, George DJ, Kantoff PW. Mutations in ribonuclease L gene do not occur at a greater frequency in patients with familial prostate cancer compared with patients with sporadic prostate cancer. Clin Prostate Cancer. 2003 Dec;2(3):177–80.
Downing, Sean R., et al. “Mutations in ribonuclease L gene do not occur at a greater frequency in patients with familial prostate cancer compared with patients with sporadic prostate cancer.Clin Prostate Cancer, vol. 2, no. 3, Dec. 2003, pp. 177–80. Pubmed, doi:10.3816/cgc.2003.n.027.
Downing SR, Hennessy KT, Abe M, Manola J, George DJ, Kantoff PW. Mutations in ribonuclease L gene do not occur at a greater frequency in patients with familial prostate cancer compared with patients with sporadic prostate cancer. Clin Prostate Cancer. 2003 Dec;2(3):177–180.

Published In

Clin Prostate Cancer

DOI

ISSN

1540-0352

Publication Date

December 2003

Volume

2

Issue

3

Start / End Page

177 / 180

Location

United States

Related Subject Headings

  • Ribonucleases
  • Prostatic Neoplasms
  • Polymerase Chain Reaction
  • Oncology & Carcinogenesis
  • Mutation
  • Middle Aged
  • Male
  • Humans
  • Gene Frequency
  • DNA Mutational Analysis